Provided by Tiger Trade Technology Pte. Ltd.

Protagenic Therapeutics Inc

1.67
-0.0100-0.60%
Post-market: 1.65-0.0192-1.15%18:19 EST
Volume:83.54K
Turnover:140.73K
Market Cap:3.23M
PE:-0.13
High:1.80
Open:1.71
Low:1.60
Close:1.68
52wk High:14.28
52wk Low:1.60
Shares:1.93M
Float Shares:1.91M
Volume Ratio:0.76
T/O Rate:4.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0507
EPS(LYR):-15.7868
ROE:-512.79%
ROA:-189.60%
PB:-36.58
PE(LYR):-0.11

Loading ...

Company Profile

Company Name:
Protagenic Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
2004
Employees:
- -
Office Location:
701 Anacapa Street,Suite C,Santa Barbara,California,United States
Zip Code:
93101
Fax:
- -
Introduction:
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

Directors

Name
Position
Garo H. Armen
Executive Chairman of the Board
Brian Corvese
Independent Director
Jennifer Buell
Independent Director
Timothy R. Wright
Independent Director
Barrett Evans
Director
Colin Stott
Director

Shareholders

Name
Position
Alexander K. Arrow
Chief Financial Officer
Andrew Slee
Chief Development Officer
Garo H. Armen
Executive Chairman of the Board
Robert B. Stein
Chief Medical Officer